Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1

Gene Therapy, Published online: 25 January 2022; doi:10.1038/s41434-022-00316-7Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1

Source: Gene Therapy - January 25, 2022 Category: Genetics & Stem Cells Authors: Siham Ait Benichou Dominic Jauvin Thi éry De Serres-Bérard Marion Pierre Karen K. Ling C. Frank Bennett Frank Rigo Genevieve Gourdon Mohamed Chahine Jack Puymirat Source Type: research